| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 37654* | 2017 |
| Short-course radiation plus temozolomide in elderly patients with glioblastoma JR Perry, N Laperriere, CJ O’Callaghan, AA Brandes, J Menten, C Phillips, ... New England Journal of Medicine 376 (11), 1027-1037, 2017 | 1176 | 2017 |
| Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre … R Stupp, ME Hegi, T Gorlia, SC Erridge, J Perry, YK Hong, KD Aldape, ... The lancet oncology 15 (10), 1100-1108, 2014 | 1158 | 2014 |
| Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ... The lancet oncology 18 (10), 1373-1385, 2017 | 1075 | 2017 |
| Standards of care for treatment of recurrent glioblastoma—are we there yet? M Weller, T Cloughesy, JR Perry, W Wick Neuro-oncology 15 (1), 4-27, 2013 | 888 | 2013 |
| Blood-brain barrier opening in primary brain tumors with non-invasive MR-guided focused ultrasound: a clinical safety and feasibility study T Mainprize, N Lipsman, Y Huang, Y Meng, A Bethune, S Ironside, ... Scientific reports 9 (1), 321, 2019 | 564 | 2019 |
| Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the cancer care Ontario practice guidelines initiative‘s neuro-oncology … DA Loblaw, J Perry, A Chambers, NJ Laperriere Journal of clinical oncology 23 (9), 2028-2037, 2005 | 449 | 2005 |
| Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study JR Perry, K Bélanger, WP Mason, D Fulton, P Kavan, J Easaw, C Shields, ... Journal of clinical oncology 28 (12), 2051-2057, 2010 | 443 | 2010 |
| Vorasidenib in IDH1-or IDH2-mutant low-grade glioma IK Mellinghoff, MJ Van Den Bent, DT Blumenthal, M Touat, KB Peters, ... New England Journal of Medicine 389 (7), 589-601, 2023 | 372 | 2023 |
| The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence‐based review LC Marras, WH Geerts, JR Perry Cancer 89 (3), 640-646, 2000 | 359 | 2000 |
| PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma JR Perry, JA Julian, NJ Laperriere, W Geerts, G Agnelli, LR Rogers, ... Journal of Thrombosis and Haemostasis 8 (9), 1959-1965, 2010 | 260 | 2010 |
| Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of … LB Nabors, KL Fink, T Mikkelsen, D Grujicic, R Tarnawski, DH Nam, ... Neuro-oncology 17 (5), 708-717, 2015 | 247 | 2015 |
| Gliadel wafers in the treatment of malignant glioma: a systematic review J Perry, A Chambers, K Spithoff, N Laperriere Current oncology 14 (5), 189, 2007 | 230 | 2007 |
| Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma C Happold, T Gorlia, O Chinot, MR Gilbert, LB Nabors, W Wick, SL Pugh, ... Journal of Clinical Oncology 34 (7), 731-739, 2016 | 223 | 2016 |
| Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma DA Reardon, LB Nabors, WP Mason, JR Perry, W Shapiro, P Kavan, ... Neuro-oncology 17 (3), 430-439, 2015 | 191 | 2015 |
| Optimal management of elderly patients with glioblastoma N Laperriere, M Weller, R Stupp, JR Perry, AA Brandes, W Wick, ... Cancer treatment reviews 39 (4), 350-357, 2013 | 182 | 2013 |
| Thromboembolic disease in patients with high-grade glioma JR Perry Neuro-oncology 14 (suppl_4), iv73-iv80, 2012 | 180 | 2012 |
| Temozolomide as salvage treatment in primary brain lymphomas M Reni, F Zaja, W Mason, J Perry, E Mazza, M Spina, R Bordonaro, ... British journal of cancer 96 (6), 864-867, 2007 | 175 | 2007 |
| Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG DT Blumenthal, T Gorlia, MR Gilbert, MM Kim, L Burt Nabors, WP Mason, ... Neuro-oncology 19 (8), 1119-1126, 2017 | 168 | 2017 |
| Consensus against both endarterectomy and routine screening for asymptomatic carotid artery stenosis JR Perry, JP Szalai, JW Norris Archives of neurology 54 (1), 25-28, 1997 | 165 | 1997 |
Arjun SahgalRadiation Oncology, Sunnybrook Health Sciences CentreVerified email at sunnybrook.ca
